Join the Collaboration Group

At Cure Cancer, we are dedicated to kick-starting new research ideas for every cancer. Working together with our donors, partners, researchers and institutes we aim to find outcomes for cancer as quickly as we can. We can't get there without you.  

An exclusive alliance

The Collaboration is an exclusive alliance of like-minded philanthropists who invest a minimum annual donation of $1,000 to support our brightest emerging cancer researchers.

As a member of The Collaboration, you will be working in partnership with other dedicated individuals who are passionate about supporting ground-breaking, innovative ideas in the shared belief that this is the key to curing cancer.

Members can choose to make donations directly or to initiate disbursements from personal foundations.

  • 1
  • 2
  • 3

Become a Collaboration member

$1,250
Provides cutting edge software to analyse cells
$2,250
Pays for antibody tests to determine the cancer subtype
$6,750
Provides high-end computing systems to analyse biological molecules
$12,500
Provides advanced sequencing technology to analyse cells
$

Your Details

Payment Details

$0.00 yearly

I'd like to add a little extra to help cover fees.

Member benefits

Your donation will make an invaluable impact to cancer research.  

A reliable donation from our collaboration members means we can plan ahead and commit to long-term new research projects which have the biggest impact to help cure cancer.

As a collaboration member, you will recieve exclusive benefits including invitations to our intimate lab tours to meet our brilliant scientists, invitations to our annual Researcher Showcase and Awards events and year round updates on the work our researchers are undertaking with your help. 

To learn more about The Collaboration or to initiate a donation from your Foundation, please contact Kat on 02 8072 6110 or via email at katrina@curecancer.com.au

Let's stay in touch

To receive updates on our work, campaigns and our impact in cancer research, subscribe to our newsletter.